| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $202.6M | -13.7% |
| Cost of Revenue | $112.6M | -56.9% |
| Gross Profit | $90.0M | +436.5% |
| R&D Expense | $58.3M | -32.4% |
| SG&A Expense | $133.8M | -34.2% |
| Operating Income | -$180.6M | +73.0% |
| Pre-tax Income | -$176.7M | +70.5% |
| Income Tax | -$926K | +98.1% |
| Net Income | -$175.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.7M | -19.6% |
| Short-term Investments | $30.5M | — |
| Inventory | $8.8M | -35.8% |
| Current Assets | $182.3M | -14.2% |
| Total Assets | $418.8M | -14.7% |
| Current Liabilities | $58.8M | -59.2% |
| Long-term Debt | $56.3M | +411.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$180.1M | +43.6% |
| Capital Expenditures | $5.3M | -26.6% |
| Investing Cash Flow | -$43.7M | +69.1% |
| Financing Cash Flow | $186.2M | -5.6% |
| Free Cash Flow | -$185.4M | +43.2% |
| +68.0% |
| EPS (Basic) | -$7.23 | -343.6% |
| EPS (Diluted) | -$7.23 | -343.6% |
| Total Liabilities |
| $190.7M |
| -19.6% |
| Stockholders' Equity | $228.0M | -10.1% |